Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device

Investor Relations, Videos

April 18, 2024 12:07 PM

Link to site HERE.

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

April 24, 2025

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

April 23, 2025

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

April 21, 2025